Lund, Sweden · Founded 2019 · Privately Held (backing)
Developer of a biopharmaceutical platform intended to develop proprietary peptides for the prevention and treatment of wounds and topical applications. Xinnate is based in Lund, Sweden and was founded in 2019. Its last reported valuation was $38.8 million in Dec 2022. It has raised $16.1 million.
These 4 firms already write checks for companies like Xinnate. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.